Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose for Chronic Fatigue in IBD
NCT02517151Phase 2Unknown
- Sponsor
- Humanitas Research Hospital
- Start
- Oct 2014
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric carboxymaltose in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), iron deficiency anemia (IDA), sponsored by Humanitas Research Hospital. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02517151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517151.